Nikko Khazana and Mark Mozley will help drive growth of NantHealth’s
portfolio, including GPS Cancer® and Liquid GPS products
CULVER CITY, Calif.--(BUSINESS WIRE)--Sep. 7, 2018--
Inc., (NASDAQ: NH), a leading next-generation, evidence-based,
personalized healthcare company, announced new executive appointments to
lead the company’s strategy and business development as well as global
Nikko Khazana will serve as NantHealth’s Senior Vice President for
Strategy and Business Development. Mark Mozley takes on the role of
Senior Vice President for Global Sales at the company.
Khazana brings more than 25 years working in corporate strategy,
business development, sales and marketing to his new role at NantHealth.
As Senior Vice President for Strategy and Business Development, Khazana
will play a crucial role in identifying growth opportunities for GPS
Cancer® to drive global business growth, financial performance and
strategy execution for the entire NantHealth healthcare solutions
Prior to joining NantHealth, Khazana held senior executive management
positions in strategy, sales, marketing, and operations at IQVIA,
Integra Connect, CompanionDx Reference Lab, Cardinal Health Specialty,
AmerisourceBergen Specialty, and Tyco International.
Mozley brings more than 15 years of experience leading sales
organizations in both the United States and abroad to his new role as
Senior Vice President for Global Sales. He joins from Clarivate
Analytics, a global data and analytics company, where he led the firm’s
life sciences and global strategic accounts teams. Mozley brings
expertise across the pharmaceutical sector with experience in
bioinformatics, competitive intelligence, regulatory, and professional
“Nikko and Mark will bring innovative ideas and excitement around our
products and services as we continue our global expansion in
next-generation, evidence-based, personalized healthcare,” said Ron
Louks, Chief Operating Officer for NantHealth. “These seasoned
executives will elevate NantHealth’s product portfolio to the next level
enabling accelerated market adoption and growth in the future.”
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a
next-generation, evidence-base, personalized healthcare company enabling
improved patient outcomes and more effective treatment decisions for
critical illnesses. NantHealth’s focused portfolio exemplifies its
unique systems-based approach to personalized healthcare and integrates
novel analysis with large-scale, biometric and phenotypic data to track
patient outcomes and deliver precision medicine. For more information
please visit www.nanthealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180907005091/en/
Source: NantHealth, Inc.